Related Experiment Video
Updated: Jun 15, 2026

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
PTEN silencing reverses aging-related impairment of angiogenesis in microvascular endothelial cells
Andrzej S Tarnawski1, Rama Pai, Tetsuya Tanigawa
1Medical Service, VALBHS and Department of Medicine, University of California Irvine, Long Beach, CA 90822, USA. atarnawski@yahoo.com
Abstract:
Aging is associated with impaired angiogenesis (new blood vessels formation from the endothelial cells of pre-existing vessels) in a variety of tissues. The precise mechanisms of aging-related impairment of angiogenesis are not known. PTEN is a dual-specificity phosphatase that antagonizes in some cells the PI3K/Akt signaling pathway, important for cell survival, function and angiogenesis. PTEN's role in aging-related impairment of angiogenesis is not known. In this study, we investigated whether expression of PTEN in endothelial cells may play a mechanistic role in aging-related impairment of angiogenesis. We demonstrated that human microvascular endothelial cells (HMVEC) derived from aging individuals (Aged-HMVEC) have: (1) significantly increased PTEN mRNA and protein levels and (2) impaired in vitro angiogenesis vs. neonatal derived HMVEC (Neo-HMVEC), and that (3) downregulation of PTEN using specific siRNA restores angiogenesis in Aged-HMVEC to normal. This is the first demonstration of increased PTEN expression in human microvascular endothelial cells derived from aging tissues and that elevated PTEN is a major factor responsible for aging-related impairment of in vitro angiogenesis.
Insights
Aging impairs new blood vessel formation due to increased PTEN protein in endothelial cells. Reducing PTEN levels in aged cells restores normal angiogenesis, revealing a key mechanism in aging vascular health.
Area of Science:
- Vascular Biology
- Cellular Aging
- Molecular Mechanisms of Aging
Background:
- Aging is linked to reduced angiogenesis, the formation of new blood vessels.
- The precise molecular causes of age-related angiogenesis impairment remain unclear.
- PTEN (Phosphatase and Tensin homolog) is a phosphatase that negatively regulates the PI3K/Akt pathway, crucial for cell survival and angiogenesis.
Purpose of the Study:
- To investigate the role of PTEN expression in endothelial cells in age-related angiogenesis impairment.
- To determine if elevated PTEN contributes to the reduced ability of aged cells to form new blood vessels.
Main Methods:
- Compared PTEN mRNA and protein levels in human microvascular endothelial cells (HMVEC) from aging and neonatal donors.
- Assessed in vitro angiogenesis capacity of Aged-HMVEC versus neonatal HMVEC (Neo-HMVEC).
- Utilized small interfering RNA (siRNA) to downregulate PTEN expression in Aged-HMVEC.
Main Results:
- Aged-HMVEC exhibited significantly higher PTEN mRNA and protein levels compared to Neo-HMVEC.
- Aged-HMVEC demonstrated impaired in vitro angiogenesis.
- Downregulation of PTEN in Aged-HMVEC using siRNA restored their angiogenic capacity to levels comparable to Neo-HMVEC.
Conclusions:
- This study provides the first evidence of increased PTEN expression in microvascular endothelial cells from aging human tissues.
- Elevated PTEN levels are identified as a major contributing factor to the impairment of in vitro angiogenesis observed in aging.
- Targeting PTEN may offer a therapeutic strategy to counteract age-related vascular dysfunction.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Replicative Cell Senescence